399 followers
Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chro…https://t.co/fycK1eGA3H
Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chro…https://t.co/fycK1eGA3H
RT @atscommunity: Roflumilast can be considered as an alternative therapy in certain #COPD patients: https://t.co/7VrNr9Uwoy
RT @atscommunity: Roflumilast can be considered as an alternative therapy in certain #COPD patients: https://t.co/7VrNr9Uwoy
RT @atscommunity: Roflumilast can be considered as an alternative therapy in certain #COPD patients: https://t.co/7VrNr9Uwoy